MA52938A - Composés inhibiteurs d'oga - Google Patents

Composés inhibiteurs d'oga

Info

Publication number
MA52938A
MA52938A MA052938A MA52938A MA52938A MA 52938 A MA52938 A MA 52938A MA 052938 A MA052938 A MA 052938A MA 52938 A MA52938 A MA 52938A MA 52938 A MA52938 A MA 52938A
Authority
MA
Morocco
Prior art keywords
inhibitor compounds
oga inhibitor
oga
compounds
inhibitor
Prior art date
Application number
MA052938A
Other languages
English (en)
Inventor
José Manuel Bartolomé-Nebreda
Lucas Olivares Ana Isabel De
Francisca Delgado-Jiménez
Andrés Avelino Trabanco-Suárez
Ramiro Juan Antonio Vega
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MA52938A publication Critical patent/MA52938A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA052938A 2018-06-20 2019-06-20 Composés inhibiteurs d'oga MA52938A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18382450 2018-06-20

Publications (1)

Publication Number Publication Date
MA52938A true MA52938A (fr) 2021-04-28

Family

ID=62784077

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052938A MA52938A (fr) 2018-06-20 2019-06-20 Composés inhibiteurs d'oga

Country Status (8)

Country Link
US (1) US20210300900A1 (fr)
EP (1) EP3810595A1 (fr)
JP (1) JP2021528412A (fr)
CN (1) CN112334462A (fr)
AU (1) AU2019291097A1 (fr)
CA (1) CA3102903A1 (fr)
MA (1) MA52938A (fr)
WO (1) WO2019243531A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018154133A1 (fr) * 2017-02-27 2018-08-30 Janssen Pharmaceutica Nv Dérivés de [1,2,4]-triazolo [1,5-a]-pyrimidinyle substitués par de la pipéridine, de la morpholine ou de la pipérazine utilisés en tant qu'inhibiteurs d'oga
US12180205B2 (en) 2018-09-19 2024-12-31 Biogen Ma Inc. O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3868752A1 (fr) * 2014-08-28 2021-08-25 Asceneuron SA Inhibiteurs de la glycosidase
AU2017222958B2 (en) * 2016-02-25 2019-07-18 Asceneuron S. A. Glycosidase inhibitors
US20190152992A1 (en) * 2016-06-29 2019-05-23 Orion Corporation Benzodioxane derivatives and their pharmaceutical use
EP3555087A1 (fr) * 2016-12-16 2019-10-23 Janssen Pharmaceutica NV Composés inhibiteurs d'oga monocyclique

Also Published As

Publication number Publication date
US20210300900A1 (en) 2021-09-30
CN112334462A (zh) 2021-02-05
WO2019243531A1 (fr) 2019-12-26
EP3810595A1 (fr) 2021-04-28
JP2021528412A (ja) 2021-10-21
AU2019291097A1 (en) 2020-12-17
CA3102903A1 (fr) 2019-12-26

Similar Documents

Publication Publication Date Title
MA52939A (fr) Composés inhibiteurs d'oga
MA52942A (fr) Composés inhibiteurs d'oga
MA47420A (fr) Composés inhibiteurs d'oga
IL292753A (en) Compounds
MA47575A (fr) Composés inhibiteurs d'oga monocyclique
EP3836923A4 (fr) Composés pyrrolo-dipyridine
MA47576A (fr) Composés inhibiteurs d'oga bicyclique
EP3941898C0 (fr) Composés fongicides
MA52948A (fr) Composés
IL286833A (en) Compositions containing brazzein
EP3737672A4 (fr) Composés benzamide
MA51669A (fr) Composés
DK4083038T3 (da) Pyridazinylthiazolcarboxamidforbindelse
EP3906029A4 (fr) Inhibiteurs de l'interaction ménine-mll
EP3464275A4 (fr) Composés inhibiteurs de l'egfr
MA53003A (fr) Composés
MA52004A (fr) Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glycopyranosidase
MA49006A (fr) Inhibiteurs d'ip6k
MA54521A (fr) Dérivés d'oxopyridine substitués
MA52946A (fr) Composés
EP3808747A4 (fr) Composé d'imidazopyridinone
EP4077318A4 (fr) Composés
MA53648A (fr) Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glucopyranosidase
EP3833342A4 (fr) Composés d'imidazotétrazine
EP4003986A4 (fr) Composés inhibiteurs